Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.7 $0 (0%) RKDA stock closing price Mar 24, 2017 (Closing)

A thorough fundamental analysis involves using data from Arcadia Biosciences balance sheet, apart from other financial statements, to value the business. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Arcadia Biosciences stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. The Arcadia Biosciences balance sheet for 2015 shows cash on hand of $23.97M. The cash has increased by $7.4M. Arcadia Biosciences revenue was $5.41M and Arcadia Biosciences operating cash flow was $-15.1M. View latest and last 10 year balance sheet data to check Arcadia Biosciences financial performance..

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Cash23.97M16.57M2.83M
Marketable Securities26.27M--
Receivables0.78M1.42M1.02M
Inventory0.29M0.42M0.45M
Raw Materials---
Work In Progress---
Finished Goods---
Notes Receivable---
Other Current Assets0.69M0.27M0.25M
Arcadia Biosciences Total Current Assets
52.01M18.69M4.56M
Property Plant & Equipment5.24M5.38M5.27M
Accumulated Depreciation4.65M4.65M4.33M
Arcadia Biosciences Net Property Plant & Equipment
0.58M0.72M0.94M
Investment & Advances19.74M0.5M1.43M
Other Non-Current Assets1.86M2.14M2.53M
Deferred Charges---
Intangibles---
Deposits & Other Assets0.02M2.81M0.06M
Arcadia Biosciences Total Assets
74.24M24.88M9.54M
Notes Payable-5.6M4.56M
Accounts Payable2.42M3.19M2.51M
Current Portion Long-Term Debt---
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities1.02M2.46M2.46M
Arcadia Biosciences Total Current Liabilities
3.45M11.26M9.54M
Mortgages---
Deferred Taxes/Income2.63M3.63M4.37M
Convertible Debt---
Long-Term Debt24.93M8.86M9.92M
Non-Current Capital Leases---
Other Long-Term Liabilities3M3M3M
Arcadia Biosciences Total Liabilities
34.01M26.77M26.83M
Minority Interest---
Preferred Stock-82.88M-
Common Stock Net0.04M--
Capital Surplus172.22M29.2M78.33M
Retained Earnings-131.92M-113.97M-95.63M
Treasury Stock---
Other Liabilities-0.11M--
Arcadia Biosciences Shareholders Equity
40.22M-1.88M-17.29M
Arcadia Biosciences Total Liabilities & Shareholders Equity
74.24M24.88M9.54M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Balance sheet for another ticker

The latest Arcadia Biosciences stock price, and Arcadia Biosciences historical stock prices show the stock price movement over time, and the Arcadia Biosciences PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for RKDA stock as of year is $74.24M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Arcadia Biosciences for 2015 total to $34.01M. Liabilities for a company like Arcadia Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.
.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
14.57
Debt to Equity ratio
0.91
Asset Turnover
ratio
0.07
receivables turnover
ratio
6.49
PB ratio (
price to book ratio
)
0.9810